• Benign Prostatic Hyperplasia
  • Hormone Therapy
  • Genomic Testing
  • Next-Generation Imaging
  • UTUC
  • OAB and Incontinence
  • Genitourinary Cancers
  • Kidney Cancer
  • Men's Health
  • Pediatrics
  • Female Urology
  • Sexual Dysfunction
  • Kidney Stones
  • Urologic Surgery
  • Bladder Cancer
  • Benign Conditions
  • Prostate Cancer

New Urology Products & Services

Article

Information on new products from Endo Pharmaceuticals, Envisionier Medical Technologies, biolitec, Inc., and Mission Pharmacal.

Treatment for aggressive bladder cancer now available in U.S.

For more information, visit http://www.endo.com/.

Rockville, MD-Envisionier Medical Technologies' endogo portable endoscopic camera is a battery-powered, portable, hand-held endoscopic video camera with integrated viewing and archiving capability. It can be used with current optical flexible or rigid endoscopes in any clinical setting. View examinations live on the 2.4-inch TFT flip screen from the instant the camera is turned on. Users can capture still shots from the examination or record voice and video continuously. Images can be transported from the removable flash RAM drive (SD RAM) or transmitted via USB-2 to another computing device or via the AV output to a compatible video monitor.

For more information, visit http://www.envisionier.com/.

High-wattage laser facilitates minimally invasive BPH treatment

East Longmeadow, MA-biolitec, Inc.'s EVOLVE 180-watt laser system uses a 980-nm wavelength in direct contact with tissue for quick, thorough vaporization of obstructive prostate tissue with excellent hemostasis, according to the manufacturer. With the patient under local anesthesia, the laser can be used with either the side fiber or Twister fiber for a minimally invasive treatment with little post-procedure discomfort or side effects, brief recovery time, and no need for post-treatment hospitalization.

For more information, visit http://www.biolitec-us.com/.

Stone-related infection treatment is available in U.S. pharmacies

San Antonio-Mission Pharmacal's urease inhibitor, acetohydroxamic acid (Lithostat), is now available in pharmacies nationwide. As adjunctive therapy to antibiotic treatment, the agent deters urea-splitting urinary infection associated with struvite stones in patients with chronic urea-splitting UTIs. In single clinical trials, the product also reduced the rate of stone growth in patients who were not candidates for surgical stone removal.

For more information, visit http://www.lithostat.com/.

Related Videos
Gary D. Steinberg, MD, an expert on bladder cancer
Akhil Das, MD, FACS, answers a question during a video interview
Edward M. Schaeffer, MD, PhD, answers a question during a Zoom video interview
Woman talking with doctor | Image Credit: © rocketclips - stock.adobe.com
Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
Gamal M. Ghoniem, MD, FACS, ABU/FPMRS, gives an answer during a video interview
Related Content
© 2024 MJH Life Sciences

All rights reserved.